Evidence map›Paper›PMID 39323891›Full record

ArticleFrontiers in microbiology2024

Investigation of a linezolid-resistant

Nadège Lépine, José Bras-Cachinho, Eva Couratin, Coralie Lemaire, Laura Chaufour, Armelle Junchat, Marie-Frédérique Lartigue

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nadège LépineService de Bactériologie-Virologie-Hygiène, Centre Hospitalier Universitaire de Tours, Tours, France.
José Bras-CachinhoService de Bactériologie-Virologie-Hygiène, Centre Hospitalier Universitaire de Tours, Tours, France.
Eva CouratinEquipe Opérationnelle d'Hygiène, Centre Hospitalier Universitaire de Tours, Tours, France.
Coralie LemaireService de Bactériologie-Virologie-Hygiène, Centre Hospitalier Universitaire de Tours, Tours, France.
Laura ChaufourService de Bactériologie-Virologie-Hygiène, Centre Hospitalier Universitaire de Tours, Tours, France.
Armelle JunchatEquipe Opérationnelle d'Hygiène, Centre Hospitalier Universitaire de Tours, Tours, France.
Marie-Frédérique LartigueService de Bactériologie-Virologie-Hygiène, Centre Hospitalier Universitaire de Tours, Tours, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We aimed to retrospectively investigate an outbreak of linezolid-resistant Methods: Twenty of the 34 LRSE isolates were included in the study. Antimicrobial susceptibility testing was performed using the disk diffusion method and MICs of last-resort antibiotics were determined using broth microdilution or Etest Results: All LRSE strains showed high levels of resistance to linezolid (MICs ≥ 256 mg/L) and were multi-drug resistant. Linezolid resistance was associated with the 23S rRNA G2576T mutation and none of the 17 strains analyzed carried the Conclusion: Linezolid exposure may promote the survival and spread of LRSE strains. At Tours University Hospital, acquisition of the resistant clone may also have been triggered by hand-to-hand transmission by healthcare workers. In addition, IR-Biotyper

Indexed as

genotypingIR-Biotyper®linezolidmulti-drug resistancesequence type ST2Staphylococcus epidermidis

Identifiers

PMID39323891
PMCPMC11422107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.